Save your place

Sign in to WhoBought

Please try again later.

Eton Pharmaceuticals, Inc. (ETON) institutional ownership

Latest close $41.07 Jul 20, 2026
Market cap$379M 52-week range SectorHealthcare
Funds holding · Q1 2026
110
reported ETON position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
61 buyers · 49 sellers

Eton Pharmaceuticals, Inc. (ETON) price and institutional activity

Dates

Q1 2026

$0 bought by 61 investors
Pillsbury Lake Capital LLCPanoramic Capital, LLC +59 more
$0 sold by 49 investors
Jefferies Financial Group Inc.Bridgeway Capital Management, LLC +47 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Eton Pharmaceuticals, Inc. (ETON) institutional activity · 110

Investor Type Est. change Change Δ Own Date
Pillsbury Lake Capital LLC · New
Change +365K Date Q1 2026
Pillsbury Lake Capital LLC New· Q1 2026 +365K Q1 2026
Panoramic Capital, LLC · New
Change +185K Date Q1 2026
Panoramic Capital, LLC New· Q1 2026 +185K Q1 2026
Soleus Capital Management, L.P. · New
Change +166K Date Q1 2026
Soleus Capital Management, L.P. New· Q1 2026 +166K Q1 2026
Prelude Capital Management, LLC · Added
Change +143K Date Q1 2026
Prelude Capital Management, LLC Added· Q1 2026 +143K Q1 2026
Ecor1 Capital, LLC · Added
Change +141K Date Q1 2026
Ecor1 Capital, LLC Added· Q1 2026 +141K Q1 2026
Cannell Capital LLC · Added
Change +125K Date Q1 2026
Cannell Capital LLC Added· Q1 2026 +125K Q1 2026
Jefferies Financial Group Inc. · Exited
Change −118K Δ Own −100.0% Date Q1 2026
Jefferies Financial Group Inc. Exited· Q1 2026 −118K −100.0% Q1 2026
Bridgeway Capital Management, LLC · Exited
Change −84K Δ Own −100.0% Date Q1 2026
Bridgeway Capital Management, LLC Exited· Q1 2026 −84K −100.0% Q1 2026
Marshall Wace, LLP · New
Change +83K Date Q1 2026
Marshall Wace, LLP New· Q1 2026 +83K Q1 2026
Walleye Capital LLC · New
Change +82K Date Q1 2026
Walleye Capital LLC New· Q1 2026 +82K Q1 2026
Woodline Partners LP · Added
Change +75K Date Q1 2026
Woodline Partners LP Added· Q1 2026 +75K Q1 2026
Millennium Management LLC · Reduced
Change −64K Date Q1 2026
Millennium Management LLC Reduced· Q1 2026 −64K Q1 2026
Boothbay Fund Management, LLC · New
Change +56K Date Q1 2026
Boothbay Fund Management, LLC New· Q1 2026 +56K Q1 2026
Informed Momentum Co LLC · New
Change +49K Date Q1 2026
Informed Momentum Co LLC New· Q1 2026 +49K Q1 2026
Russell Investments Group, Ltd. · Reduced
Change −47K Date Q1 2026
Russell Investments Group, Ltd. Reduced· Q1 2026 −47K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 110

Famous investor activity in Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals, Inc. (ETON) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Opaleye Management Inc. · 10% Owner 2 operations −$1.1M
Price $37.54 Qty −28K Owned 40K Trade date Jul 14, 2026 Filed date Jul 16, 2026
Opaleye Management Inc. 10% Owner 2 operations $37.54 −28K −$1.1M 40K Jul 14, 2026 Jul 16, 2026
Brynjelsen Sean · Director 2 operations 400K
Price $1.37 Owned 0 Trade date Jul 14, 2026 Filed date Jul 14, 2026
Brynjelsen Sean Director 2 operations $1.37 400K 0 Jul 14, 2026 Jul 14, 2026
Brynjelsen Sean · Director 2 operations 0
Owned 0 Trade date Jul 12, 2026 Filed date Jul 14, 2026
Brynjelsen Sean Director 2 operations 0 0 Jul 12, 2026 Jul 14, 2026
Krempa David · Officer 2 operations 0
Owned 0 Trade date Jul 12, 2026 Filed date Jul 13, 2026
Krempa David Officer 2 operations 0 0 Jul 12, 2026 Jul 13, 2026
Opaleye Management Inc. · 10% Owner 2 operations −$1.0M
Price $38.37 Qty −27K Owned 53K Trade date Jul 7, 2026 Filed date Jul 7, 2026
Opaleye Management Inc. 10% Owner 2 operations $38.37 −27K −$1.0M 53K Jul 7, 2026 Jul 7, 2026
Opaleye Management Inc. · 10% Owner Sell −$380K
Price $38.00 Qty −10K Owned 2.7M ΔOwn −0.4% Trade date Jul 6, 2026 Filed date Jul 7, 2026
Opaleye Management Inc. 10% Owner Sell $38.00 −10K −$380K 2.7M −0.4% Jul 6, 2026 Jul 7, 2026
Opaleye Management Inc. · 10% Owner 2 operations −$3.4M
Price $37.39 Qty −90K Owned 60K Trade date Jul 2, 2026 Filed date Jul 7, 2026
Opaleye Management Inc. 10% Owner 2 operations $37.39 −90K −$3.4M 60K Jul 2, 2026 Jul 7, 2026
Krempa David · Officer Grant (A) 10K
Owned 97K Trade date Jun 26, 2026 Filed date Jun 30, 2026
Krempa David Officer Grant (A) 10K 97K Jun 26, 2026 Jun 30, 2026
Adams Jennifer McKie · Director Sell −$1.6M
Price $32.48 Qty −50K Owned 0 Trade date Jun 17, 2026 Filed date Jun 17, 2026
Adams Jennifer McKie Director Sell $32.48 −50K −$1.6M 0 Jun 17, 2026 Jun 17, 2026
Adams Jennifer McKie · Director 2 operations 0
Price $3.78 Owned 0 Trade date Jun 17, 2026 Filed date Jun 17, 2026
Adams Jennifer McKie Director 2 operations $3.78 0 0 Jun 17, 2026 Jun 17, 2026
Brynjelsen Sean · Director 2 operations −$3.8M
Price $31.88–$32.67 Qty −120K Owned 834K Trade date May 28, 2026 Filed date May 29, 2026
Brynjelsen Sean Director 2 operations $31.88–$32.67 −120K −$3.8M 834K May 28, 2026 May 29, 2026
Krempa David · Officer Sell −$619K
Price $31.47 Qty −20K Owned 25K Trade date May 27, 2026 Filed date May 27, 2026
Krempa David Officer Sell $31.47 −20K −$619K 25K May 27, 2026 May 27, 2026
Krempa David · Officer 4 operations 0
Price $1.37–$3.58 Owned 118K Trade date May 27, 2026 Filed date May 27, 2026
Krempa David Officer 4 operations $1.37–$3.58 0 118K May 27, 2026 May 27, 2026
Krempa David · Officer Sell −$1.2M
Price $31.49 Qty −38K Owned 25K Trade date May 26, 2026 Filed date May 27, 2026
Krempa David Officer Sell $31.49 −38K −$1.2M 25K May 26, 2026 May 27, 2026
Krempa David · Officer 4 operations 0
Price $1.37–$1.38 Owned 12K Trade date May 26, 2026 Filed date May 27, 2026
Krempa David Officer 4 operations $1.37–$1.38 0 12K May 26, 2026 May 27, 2026
15 of 38
15 of 38 Sign in to continue to older insider transactions.

Eton Pharmaceuticals, Inc. (ETON) activist and large shareholders

What are Schedules 13D and 13G?

Dates
No Schedule 13D or 13G filing is available for ETON in this range.

Eton Pharmaceuticals, Inc. (ETON) ownership FAQ

Who owns ETON?

110 reporting institutions disclosed ETON position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.